Mani Inc
TSE:7730

Watchlist Manager
Mani Inc Logo
Mani Inc
TSE:7730
Watchlist
Price: 1 790 JPY -0.72% Market Closed
Market Cap: ¥176.3B

EV/OCF

14.9
Current
24%
Cheaper
vs 3-y average of 19.4

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
14.9
=
Enterprise Value
¥160.9B
/
Operating Cash Flow
¥10.3B

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
14.9
=
Enterprise Value
¥160.9B
/
Operating Cash Flow
¥10.3B

Valuation Scenarios

Mani Inc is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (19.4), the stock would be worth ¥2 341.18 (31% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-23%
Maximum Upside
+41%
Average Upside
12%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 14.9 ¥1 790
0%
3-Year Average 19.4 ¥2 341.18
+31%
5-Year Average 20.9 ¥2 520.31
+41%
Industry Average 14.8 ¥1 780.51
-1%
Country Average 11.4 ¥1 372.75
-23%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
JP
Mani Inc
TSE:7730
176.3B JPY 14.9 23.5
US
Medline Inc
NASDAQ:MDLN
58.8B USD 0 0
JP
Hoya Corp
TSE:7741
9.7T JPY 36.2 38.6
CH
Alcon AG
SIX:ALC
29.2B CHF 17.4 37.3
DK
Coloplast A/S
CSE:COLO B
94.7B DKK 16.5 23.5
US
Align Technology Inc
NASDAQ:ALGN
13.5B USD 20.9 33
UK
ConvaTec Group PLC
LSE:CTEC
4.3B GBP 15.2 32.7
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 36.2 -15.5
JP
Asahi Intecc Co Ltd
TSE:7747
890.2B JPY 20.8 50.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
36.7B CNY 24.7 23.3
KR
HLB Inc
KOSDAQ:028300
8T KRW -86.3 -36.2
P/E Multiple
Earnings Growth PEG
JP
Mani Inc
TSE:7730
Average P/E: 32.8
23.5
22%
1.1
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
JP
Hoya Corp
TSE:7741
38.6
15%
2.6
CH
Alcon AG
SIX:ALC
37.3
32%
1.2
DK
Coloplast A/S
CSE:COLO B
23.5
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
33
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
32.7
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.5 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
50.3
40%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
9%
2.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -36.2 N/A N/A

Market Distribution

In line with most companies in Japan
Percentile
65th
Based on 4 586 companies
65th percentile
14.9
Low
0 — 8.2
Typical Range
8.2 — 16.2
High
16.2 —
Distribution Statistics
Japan
Min 0
30th Percentile 8.2
Median 11.4
70th Percentile 16.2
Max 277 515 327.6

Mani Inc
Glance View

Market Cap
176.3B JPY
Industry
Health Care

In the dynamic landscape of modern manufacturing, Mani Inc. emerges as a pivotal player, weaving together innovation and tradition in the realm of precision tools. Founded in the late 20th century, the company quickly distinguished itself by specializing in the design and production of high-quality dental and medical instruments. At its core, Mani Inc. thrives on its commitment to quality and reliability, underpinning its operations with cutting-edge technology and meticulous craftsmanship. Boasting a global presence, the company navigates a complex supply chain and adheres to stringent regulatory standards, ensuring its tools meet the diverse needs of practitioners around the world. Mani Inc. engages directly with dental professionals and healthcare institutions, building lasting relationships that are strengthened by the consistent performance and longevity of its products. Economically, Mani Inc. capitalizes on its expansive distribution network and brand loyalty to generate revenue, with a business model that focuses on both direct sales and partnerships with distributors. This approach allows the company not only to reach a wide array of international markets but also to tailor its offerings to specific regional demands. Its commitment to research and development propels innovation that further solidifies its market position, helping to safeguard against the fluctuations that often characterize the medical tools segment. By investing significantly in R&D, Mani Inc. ensures its product lineup remains at the forefront of technology and efficiency, thereby reinforcing its competitive edge in an industry where precision is paramount.

Intrinsic Value
1 476.99 JPY
Overvaluation 17%
Intrinsic Value
Price ¥1 790
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett